Group 1 - The Hong Kong stock market rebounded last week, with the Hang Seng Index rising by 2.53% or 638 points, closing at 25,858 points, despite a decrease in trading volume [1] - The overall trading volume for the week was approximately 1.09 trillion HKD, and the market remained flat for November [1] - The market is experiencing volatility due to differing views on AI narratives and a tendency for profit-taking as year-end approaches, although long-term external liquidity conditions are expected to improve [1] Group 2 - Technology stocks are gaining attention due to significant investments in AI infrastructure, with the launch of Alibaba's Quark AI glasses and Ant Group's Lingguang App generating positive market reactions [2] - The innovative drug industry is seeing opportunities as major pharmaceutical companies engage in large-scale mergers to address patent cliffs, with Eli Lilly becoming the first pharmaceutical company to surpass a market value of 1 trillion USD [2] - China is positioned as a key player in the global biopharmaceutical market, with potential growth for certain Hong Kong-listed innovative drug companies as the industry evolves [2]
【大公报】港股成交缩量，观望情绪浓厚
Xin Lang Cai Jing·2025-12-03 09:15